Skip to content

Trial · Interventional

CompletedNot applicableRegistry data

Effects of Oxytocin and Vasopressin on Moral Decision Making

NCTNCT04890470 (opens ClinicalTrials.gov in a new tab)Other idUESTC-neuSCAN-78
Open at ClinicalTrials.govAsk about this trial

Overview

Status
Completed
Phase
Not applicable
Enrollment
180 participants (actual)
Sponsor
University of Electronic Science and Technology of China · Other
Design
Randomized · Double masking
Countries
1 country

China

Start
2 Mar 2021
Primary completion
12 Dec 2022
Completion
12 Dec 2022
First posted
18 May 2021
Last update posted
21 Sept 2023
Conditions
Healthy

Timeline

1 trial · 1 completed

  • Completed
  • Ongoing
  • Not yet recruiting
  • Stopped
  • Estimated dates (est.)
  • Results posted
202120222023
  1. N/A

    Effects of Oxytocin and Vasopressin on Moral Decision Making

    NCT04890470

    2 Mar 2021 to 12 Dec 2022

Registry summary

Text and fields below are the sponsor's entries at ClinicalTrials.gov, shown as posted.

To determine whether the neuropeptide oxytocin (OXT) and vassopressin (AVP) influence moral decision making

Interventions

  • OxytocinDrug
  • VasopressinDrug
  • PlaceboDrug

Arms3

  • Experimental

    oxytocin group

    subjects with oxytocin treatment

  • Experimental

    vasopressin group

    subjects with vasopressin treatment

  • Placebo comparator

    placebo group

    subjects with placebo treatment

Primary outcomes1

Outcomes the sponsor listed as primary.

  1. Effect of OXT and AVP on behavioral index of moral decision task

    Time frame · 45 mins - 105 mins

    Registry description

    intensity of feelings

Posted results

Values are shown as posted at ClinicalTrials.gov, with their units. PepBank has not converted, pooled or compared them.

No results are posted for this trial.

Completed trials do not always post results.

Registry data comes from ClinicalTrials.gov. Study results come from studies, not from the registry. How PepBank works

Studies1

Studies that cite this trial.

Studies with results

1 study on this page

Indexing hint: Randomized controlled trial · 2024

5 results

Oxytocin, but not vasopressin, decreases willingness to harm others by promoting moral emotions of guilt and shame.

Zheng et al. 2024Molecular psychiatrycited by 7

PMID 38769372PMC11540849DOI 10.1038/s41380-024-02590-wPUB-38769372

CC BY5 results
Download PDFSee results (5)

Eligibility

Who could join, as posted.

Sex
All
Age
from 18 Years up to 30 Years
Healthy volunteers
Accepted
Inclusion and exclusion criteria, as posted
Inclusion Criteria: * healthy subjects without past or current psychiatric or neurological disorders Exclusion Criteria: * pregnancy

PepBank is a research reference. Talk to a doctor before you use any peptide.